Bipolar Disorder: Sorting Out Comorbidities

Because patients with bipolar disorder often have underlying comorbidities, a thorough diagnosis is imperative.

Related Videos
Related Content

FDA-Approved: Risperidone Extended-Release Injectable Suspension

January 17th 2023

Blue Light Blockers: A Behavior Therapy for Mania

October 7th 2021

Positive Phase III Study Results Reported for Bipolar I Disorder Treatment in Adults

December 19th 2022

A Heavy Burden: Bipolar Disorder and Obesity

November 5th 2022

NDA for Long-Acting Injectable for Schizophrenia and Bipolar I Accepted

September 13th 2022

Drug-Drug Interactions in Patients with Bipolar Disorder

May 12th 2022

FDA-Approved: Risperidone Extended-Release Injectable Suspension

January 17th 2023

Blue Light Blockers: A Behavior Therapy for Mania

October 7th 2021

Positive Phase III Study Results Reported for Bipolar I Disorder Treatment in Adults

December 19th 2022

A Heavy Burden: Bipolar Disorder and Obesity

November 5th 2022

NDA for Long-Acting Injectable for Schizophrenia and Bipolar I Accepted

September 13th 2022

Drug-Drug Interactions in Patients with Bipolar Disorder

May 12th 2022

FDA-Approved: Risperidone Extended-Release Injectable Suspension

January 17th 2023

Blue Light Blockers: A Behavior Therapy for Mania

October 7th 2021

Positive Phase III Study Results Reported for Bipolar I Disorder Treatment in Adults

December 19th 2022

A Heavy Burden: Bipolar Disorder and Obesity

November 5th 2022

NDA for Long-Acting Injectable for Schizophrenia and Bipolar I Accepted

September 13th 2022

Drug-Drug Interactions in Patients with Bipolar Disorder

May 12th 2022
© 2023 MJH Life Sciences

All rights reserved.